137 related articles for article (PubMed ID: 8634990)
1. The molecular basis of ovarian cancer.
Gallion HH; Pieretti M; DePriest PD; van Nagell JR
Cancer; 1995 Nov; 76(10 Suppl):1992-7. PubMed ID: 8634990
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in the ovary.
Berchuck A
J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
[TBL] [Abstract][Full Text] [Related]
3. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
4. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
[TBL] [Abstract][Full Text] [Related]
5. Human ovarian cancer of the surface epithelium.
Berchuck A; Carney M
Biochem Pharmacol; 1997 Sep; 54(5):541-4. PubMed ID: 9337069
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
7. Genetics and ovarian carcinoma.
Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK
Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
Neuhausen SL; Marshall CJ
Cancer Res; 1994 Dec; 54(23):6069-72. PubMed ID: 7954448
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
Rhei E; Bogomolniy F; Federici MG; Maresco DL; Offit K; Robson ME; Saigo PE; Boyd J
Cancer Res; 1998 Aug; 58(15):3193-6. PubMed ID: 9699640
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal PA; Liu Q; Shattuck-Eidens D; Cochran C; Harshman K; Tavtigian S; Bennett LM; Haugen-Strano A; Swensen J; Miki Y
Science; 1994 Oct; 266(5182):120-2. PubMed ID: 7939630
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the BRCA1 gene in ovarian cancers.
Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
[TBL] [Abstract][Full Text] [Related]
12. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Foster KA; Harrington P; Kerr J; Russell P; DiCioccio RA; Scott IV; Jacobs I; Chenevix-Trench G; Ponder BA; Gayther SA
Cancer Res; 1996 Aug; 56(16):3622-5. PubMed ID: 8705994
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the BRCA1 gene in human cancer.
Xu CF; Solomon E
Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of ovarian carcinomas.
Matias-Guiu X; Prat J
Virchows Arch; 1998 Aug; 433(2):103-11. PubMed ID: 9737787
[TBL] [Abstract][Full Text] [Related]
17. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of ovarian cancers.
Berchuck A; Elbendary A; Havrilesky L; Rodriguez GC; Bast RC
J Soc Gynecol Investig; 1994; 1(3):181-90. PubMed ID: 9419769
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the BRCA2 gene in ovarian carcinomas.
Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
